These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7811275)
41. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914 [TBL] [Abstract][Full Text] [Related]
42. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1. Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644 [TBL] [Abstract][Full Text] [Related]
43. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451 [TBL] [Abstract][Full Text] [Related]
44. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Morris L; Allen KE; La Thangue NB Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242 [TBL] [Abstract][Full Text] [Related]
45. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. Steiner P; Philipp A; Lukas J; Godden-Kent D; Pagano M; Mittnacht S; Bartek J; Eilers M EMBO J; 1995 Oct; 14(19):4814-26. PubMed ID: 7588611 [TBL] [Abstract][Full Text] [Related]
46. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Woo MS; Sánchez I; Dynlacht BD Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292 [TBL] [Abstract][Full Text] [Related]
47. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Vadiveloo PK; Filonzi EL; Stanton HR; Hamilton JA Atherosclerosis; 1997 Aug; 133(1):61-9. PubMed ID: 9258408 [TBL] [Abstract][Full Text] [Related]
48. Association of cyclin A and cdk2 with SV40 DNA in replication initiation complexes is cell cycle dependent. Cannella D; Roberts JM; Fotedar R Chromosoma; 1997 Apr; 105(6):349-59. PubMed ID: 9087377 [TBL] [Abstract][Full Text] [Related]
49. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Beijersbergen RL; Carlée L; Kerkhoven RM; Bernards R Genes Dev; 1995 Jun; 9(11):1340-53. PubMed ID: 7797074 [TBL] [Abstract][Full Text] [Related]
50. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. Carroll JS; Prall OW; Musgrove EA; Sutherland RL J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938 [TBL] [Abstract][Full Text] [Related]
51. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mateyak MK; Obaya AJ; Sedivy JM Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516 [TBL] [Abstract][Full Text] [Related]
52. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells. Yu B; Lane ME; Wadler S Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612 [TBL] [Abstract][Full Text] [Related]
53. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. Voit R; Hoffmann M; Grummt I EMBO J; 1999 Apr; 18(7):1891-9. PubMed ID: 10202152 [TBL] [Abstract][Full Text] [Related]
54. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product. Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470 [TBL] [Abstract][Full Text] [Related]
55. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells. Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533 [TBL] [Abstract][Full Text] [Related]
56. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430 [TBL] [Abstract][Full Text] [Related]
57. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related]
58. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression. Keenan SM; Lents NH; Baldassare JJ J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251 [TBL] [Abstract][Full Text] [Related]
59. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171 [TBL] [Abstract][Full Text] [Related]
60. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]